Hemispherx (HEB) Updates on FDA Panel Vote for Ampligen; Fails to Win Backing
Go back to Hemispherx (HEB) Updates on FDA Panel Vote for Ampligen; Fails to Win BackingHEMISPHERX BIOPHARMA, Inc. (NYSE: HEB) | Delayed: 1.80 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.80 | 52 Week High | $1.48 | |||
Open | $1.46 | 52 Week Low | $0.06 | |||
Day High | $1.80 | P/E | N/A | |||
Day Low | $1.80 | EPS | $-0.11 | |||
Volume | 94,971 |